Trevena CEO to Present at the 9(th) Annual JMP Securities Healthcare Conference

June 18, 2014 11:05 AM

16 0

Trevena, Inc. (NASDAQ:TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present at the 9th Annual JMP Securities Healthcare Conference on Wednesday, June 25, 2014 at 11:00 a.m. EDT at The Westin Grand Central in New York City.

To access a live audio webcast of the presentation, please visit the "Investors" section at The webcast will be archived for 30 days.

Read more

To category page